자유게시판

이스라엘 뉴스] 오미크론, 미접종자 중증확률 2.4배

작성자 도렽
작성일 2021.12.02 09:10

조회 29,959
댓글 20
목록 목록

글수정 글삭제

뉴스링크 : https://www.jpost.com/health-and-wellness/coronavirus/covid-1st-data-about-vaccine-efficacy-against-omicron-expected-tuesday-687392

[요약]

이스라엘 보건장관 피셜에 따르면 현재까지 데이터로 분석할 때,

오미크론의 전파력은 델타변이의 1.3배

미접종자의 중증확률은 2.4배

공식적으로 확정된 데이터는 아님

COVID: First signs that vaccine protects against Omicron – health minister

here are indications that individuals fully vaccinated against corona within six months or with the booster are also protected against the Omicron variant, Health Minister Nitzan Horowitz said on Tuesday, after another two cases were identified, bringing the total to four.

“In the coming days we will have more accurate information about the efficacy of the vaccine against Omicron, but there is already room for optimism, and there are initial indications that those who are vaccinated with a vaccine still valid or with a booster will also be protected from this variant,” Horowitz said while visiting the Soroka Medical Center in Beersheba with Finance Minister Avigdor Liberman.

The Health & Wellness portal is presented in collaboration withSamson Assuta Ashdod University Hospital >>

“The vaccine is really crucial right now,” said Horowitz. “Anyone who is exposed to the variant without a vaccine will put themselves at unnecessary risk.”

Later in the evening, a report by Channel 12 said the Pfizer vaccine is just slightly less effective in preventing infection with Omicron than with Delta – 90% as opposed to 95% – while it is as effective – around 93% – in preventing serious symptoms at least for those vaccinated with a booster.

According to the report, the ability of the variant to infect is higher than Delta but not as much as feared – around 1.3 times higher.

At the same time, those not inoculated have a 2.4 times greater chance of developing serious symptoms, a significant figure.

A spokesperson for the Health Ministry said the ministry was not yet in possession of the data published by Channel 12.

Head of Public Health Services Dr. Sharon Alroy-Preis said the first data about the efficacy of the corona vaccines against Omicron were expected to be shared with Israel by South Africa on Tuesday. However, the ministry had not yet received the information as of press time.

“The greatest concern for us is the very rapid spread of this variant in South Africa,” Alroy-Preis told the Knesset Foreign Affairs Committee, describing how the daily cases there rose from 200 cases to 2,000 cases in 10 days.

“From what we hear, those vaccinated do not have significant symptoms, it is a mild disease, but for now this is preliminary information,” she noted. “Today there will be the first data on the efficacy of the vaccine.”

Alroy-Preis explained the necessity of employing the Shin Bet (Israel Security Agency) tracking system to locate those who were in contact with individuals infected with the variant or suspected to be infected.

“The Shin Bet system is one of our tools to identify and interrupt the transmission chains,” she said. “The time it has bought for us is helping us to vaccinate the population and get our citizens to be in a more protected situation.”

As of Tuesday morning, the technology had been used to track the contacts of 13 people – two infected with Omicron and 11 possibly infected. Exactly 186 individuals were identified, 42 of whom are suspected of being infected.

In order to verify their situation, they need to undergo a corona test, and if found positive, the results need to undergo genetic sequencing to check whether they are carrying the variant or a different strain.

If the number of people to track goes up to a few hundred, Alroy-Preis noted, there won’t be a way to use the tracking technology anymore.

Two cardiologists from Sheba Medical Center were verified as infected with the Omicron variant, a spokesperson for the hospital confirmed. He said they were experiencing “very light symptoms.”

One of the doctors, in his mid 40s, brought the variant into Israel upon returning from a medical conference in London. He tested negative when he boarded the airplane from the United Kingdom to Israel and on arrival, but a few days later began experiencing symptoms.

Once he tested positive, his results were sequenced and on Tuesday he was confirmed positive for the variant.

Before entering isolation, the doctor had performed several cardiac catheterizations and attended at least two other large events. He was also in contact with the second cardiologist, in his 70s, who is now also infected with the variant.

Both doctors were fully vaccinated with three shots of the Pfizer corona vaccine.

The hospital spokesperson said that anyone the doctors were in contact with has been informed, but there are no additional suspicious cases at the medical center at this time nor news of any related outbreaks.

At Soroka, Horowitz said again that the situation in Israel is under control and there is no need to panic.

“We will not close the country and will maintain life as normal as possible,” he noted. “There is currently no intention to impose restrictions on life within Israel, and we will do everything possible to ensure that this continues.”

Horowitz also emphasized that the ban on foreign tourists is only temporary, and will not be automatically renewed.

In the meantime, the number of new cases in Israel remains stable.

Exactly 636 new virus carriers were identified on Monday. A week earlier they were 716. The total number of active cases on Tuesday stood at 5,600.

In addition, there were 117 patients in serious condition, the lowest since July.

Finally, the R rate measuring how many people each virus carrier infects slightly decreased on Tuesday, when it stood at 1.03.

댓글 20개

해참
작성일 21-12-02

그니까 접종완료자도 중증으로 간다는 야그네요.~~

단지 미접종자가 더 많이 중증으로 가는거고..

2.4배면.. 미접종자 중증화 %는 델타보다 적게 나오네요..

전체적으로 약화된 바이러스라서 그런가??

그런데 저 기사는 결과치가 아니라 예상치..~~

몇명 안되는 감염자가지고 말하기는???

더 상황을 지켜봐야 할것 같음.

간혹 예측 나오는것은 치명율 낮아진 전파력이 강한 거라고 하지만.~

추천0 비추천0

오라클OR
작성일 21-12-02

중증화율이 델타보다 2.4배라는 의미입니다.

2.4%가 아니고...

추천0 비추천0

해참
작성일 21-12-02

델타보다 2.4배가 아니라..

오미크론에서 접종자와 미접종자 차이가 2.4배 아닌가요?

그리고 델타에서는 접종자와 비접종자 차이가 22배라고 뉴스나 여기 글이나 댓글에서 하는것 같은데..

2.4% 라고 해서 내가 % 이야기 한것이 아니구요.. 어차비 2.4배는 %로 계산한거잖아요.

https://www.medifonews.com/news/article.html?no=163406

그리고 솔직히 저 기사는 의미 없음.~~~

그냥 내가 보기에는 이스라엘에서 부스터샵 접종해야 한다 당위성 홍보하기 위해서 발표 한것 같음.

추천0 비추천0

fdjvgfh
작성일 21-12-02

미접종자는 델타보다 중증화 확률이 2.4배 더 높다는거 같은데요

추천0 비추천0

해참
작성일 21-12-02

내가 그 이야기 한것임.

델타에서는 접종자보다 미접종자가 22배 더 높다고 한것 같은데...

그럼 오미크론은 ..2.4배면 델타보다는 차이가 작아진거죠.

https://www.medifonews.com/news/article.html?no=163406

저 기사는 별 의미 없고.. 자료 데이터 부족이고.

그냥 내가 보기에는 이스라엘에서 부스터샵 접종해야 한다 당위성 홍보하기 위해서 발표 한것 같음.

추천0 비추천0

fdjvgfh
작성일 21-12-02

According to the report, the ability of the variant to infect is higher than Delta but not as much as feared – around 1.3 times higher.

At the same time, those not inoculated have a 2.4 times greater chance of developing serious symptoms, a significant figure.

보고서에 따르면 이 변종의 감염 능력은 Delta보다 높지만 두려운 정도는 아닙니다(약 1.3배).

동시에, 접종하지 않은 사람들은 심각한 증상이 나타날 확률이 2.4배 더 높아 상당한 수치입니다.

--------------------------------------------------------------------------------

이부분은 델타변이에 비교해서 말한거 같은데요. 델타변이 보다 오미크론이 중증화율이 2.4배 더 높다.

오미크론 내에서 접종자와 미접종자 비교가 아닌거 같은데요.

어짜피 지금 백신이 오미크론을 얼마나 방어하는지 조차 안나온 상태인데

오미크론 내에서 접종자와 미접종자의 차이를 구하기는 더 어렵죠

추천0 비추천0

해참
작성일 21-12-02

아니요.델타와 비교가 아니라..

부스터샷을 접종한 사람과 미접종한사람에게 나타날수 있는 예상치..~~

부스터샷을 접종한 사람과 접종 하지 않은 사람에 나타날수 있는 그 차이.

접종자보다 미접종자 감염차이가 델타에서는 1.3배..

접종자보다 미접종자 감염차이가 오미크론에서는 2.4배라고 하네요.

즉 오미크론이 아니라 부스터샷에 대한 걸 이야기 한것임.

결론은 이스라엘은 부스터샷 접종권고 발표를 한것임.